TCR2 Alternatives & Competitors
12 companies similar to TCR2 — Pioneering the future of cancer treatment with advanced T cell engineering and u...
Companies similar to TCR2
Inceptor Bio
Advancing Cell and Gene Therapies to Cure Cancer
Morrisville, United State...
Crossbow Therapeutics, Inc
Established antibody engineering to target the untapped universe of intracellular cancer t...
Cambridge, United States
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Rebirthel Co.,Ltd.
An independent biocompany, developing cellular immunotherapies for cancer, based on Kyoto.
Kyoto, Japan
Track all TCR2 competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
2seventy bio
It’s about time we think smarter and faster than cancer.
Cambridge, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
Mestastop® Solutions
Stopping Metastasis, giving life a second chance
United States
SpecificiT Pharma
Pioneering personalized cancer therapies with a novel approach using Minor Histocompatibil...
Caedo Oncology AS
We create improved treatment options for cancer patients through unique immunotherapy oppo...
Oslo, Norway
Checkmate Pharmaceuticals
Pioneering advanced immunotherapies to amplify cancer treatment options and improve patien...
About TCR2
TCR2 is strategically positioned at the forefront of biotechnology, leveraging its profound expertise in T cell engineering to revolutionize cancer treatment. Founded in 2015 by Dr. Patrick Baeuerle and MPM Capital, the company is dedicated to pioneering innovative solutions in the pharmaceutical industry.
Development of cell therapies, Sale of cell therapies, Clinical trials, Research and development in cancer treatment
Cancer patients, Medical institutions, Healthcare providers, Pharmaceutical companies
T Cell Engineering, Cancer Treatment, T Cell Receptor Biology, Immunotherapy, Oncology, TCR2, Novel Therapies, Biopharmaceuticals, Cell Therapy, First-in-class Approach, Kendall Square, Cambridge Massachusetts, Academic Collaboration, MPM Capital
B2B, B2B2C, Platform
Licensing, Product Sales, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches TCR2 and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at TCR2 on 17 Apr 2026. The 12 companies listed here were last checked between 25 Jul 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
